cthulhu2.0
Established Member
- Reaction score
- 20
From an interesting article I read:
Stephen E. Wolverton, MD, a professor of clinical dermatology in the Department of Dermatology at Indiana University School of Medicine, conducted a review of finasteride studies in order to determine the accuracy of the new studies reporting permanent sexual side effects and was not able to come to as definitive a conclusion. In particular, Dr. Wolverton looked at a study by McClellan and Markham (1999) that included nearly 1,900 men between 18 and 41 years of age randomized to either finasteride or placebo.[SUP]3[/SUP]
According to Dr. Wolverton, the study by McClellan and Markham demonstrated that there was a slightly increased risk of sexual side effects in patients taking finasteride for male pattern baldness, including decreased libido, erectile dysfunction and ejaculation disorders, but, he adds, there are a couple of points in the article that are particularly important to the current debate about long-term side effects.
“One is that sexual adverse effects ‘resolved in many men who reported them but remained on therapy and in all men who discontinued therapy because of these adverse events,’”[SUP]3[/SUP] explains Dr. Wolverton. “So, in other words, things in any of those three categories went back to normal, even while they were still taking the drug. The other statement was that sexual adverse events resolved ‘in all men who discontinued therapy because of these adverse events.’”[SUP]3[/SUP]
The body of literature on finasteride does consistently support the existence of sexual side effects that begin while patients are on the drug, but the reports also demonstrate that, for the most part, these side effects resolve either when the drug is withdrawn or over time as therapy continues. In a report from the Finasteride Male Pattern Hair Loss Study Group, a slightly higher proportion of finasteride users compared to patients on placebo reported drug-related adverse events (AEs) that related to sexual function, but only 11 men (1.4%) treated with finasteride and 8 men (1.0%) treated with placebo discontinued the study due to these side effects.[SUP]6[/SUP] In addition, the side effects resolved in patients who discontinued finasteride and in most patients who reported them but remained on the drug.[SUP]6[/SUP] Another study published in the Journal of the American Academy of Dermatology (JAAD) concluded that no adverse events were seen significantly more often with finasteride compared to placebo.[SUP]7[/SUP] This study inJAAD also demonstrated that the side effects cleared in men who stopped taking finasteride and in most men who remained on the drug.[SUP]7[/SUP]
[SUP]I acknowledge that certain people may have continued sexual disfunction after stopping finasteride, but they are in an incredibly small minority.[/SUP]
Stephen E. Wolverton, MD, a professor of clinical dermatology in the Department of Dermatology at Indiana University School of Medicine, conducted a review of finasteride studies in order to determine the accuracy of the new studies reporting permanent sexual side effects and was not able to come to as definitive a conclusion. In particular, Dr. Wolverton looked at a study by McClellan and Markham (1999) that included nearly 1,900 men between 18 and 41 years of age randomized to either finasteride or placebo.[SUP]3[/SUP]
According to Dr. Wolverton, the study by McClellan and Markham demonstrated that there was a slightly increased risk of sexual side effects in patients taking finasteride for male pattern baldness, including decreased libido, erectile dysfunction and ejaculation disorders, but, he adds, there are a couple of points in the article that are particularly important to the current debate about long-term side effects.
“One is that sexual adverse effects ‘resolved in many men who reported them but remained on therapy and in all men who discontinued therapy because of these adverse events,’”[SUP]3[/SUP] explains Dr. Wolverton. “So, in other words, things in any of those three categories went back to normal, even while they were still taking the drug. The other statement was that sexual adverse events resolved ‘in all men who discontinued therapy because of these adverse events.’”[SUP]3[/SUP]
The body of literature on finasteride does consistently support the existence of sexual side effects that begin while patients are on the drug, but the reports also demonstrate that, for the most part, these side effects resolve either when the drug is withdrawn or over time as therapy continues. In a report from the Finasteride Male Pattern Hair Loss Study Group, a slightly higher proportion of finasteride users compared to patients on placebo reported drug-related adverse events (AEs) that related to sexual function, but only 11 men (1.4%) treated with finasteride and 8 men (1.0%) treated with placebo discontinued the study due to these side effects.[SUP]6[/SUP] In addition, the side effects resolved in patients who discontinued finasteride and in most patients who reported them but remained on the drug.[SUP]6[/SUP] Another study published in the Journal of the American Academy of Dermatology (JAAD) concluded that no adverse events were seen significantly more often with finasteride compared to placebo.[SUP]7[/SUP] This study inJAAD also demonstrated that the side effects cleared in men who stopped taking finasteride and in most men who remained on the drug.[SUP]7[/SUP]
[SUP]I acknowledge that certain people may have continued sexual disfunction after stopping finasteride, but they are in an incredibly small minority.[/SUP]